We hypothesized that TSPO PET using 18F-DPA-714 may be a potent biomarker strategy, considering that TSPO PET imaging has been used in several gliomas in preclinical and clinical studies presenting high TSPO expression compared to healthy surrounding brain tissue [21,23]. This evidence concerns the gene TSPO and central nervous system cancer.